Abstract:1-Deoxynojirimycin(DNJ) is an effective α-glucosidase inhibitor,being able to lower blood glucose efficiently.Nojirimycin was firstly found in streptomyces,while DNJ was firstly isolated from the root bark of mulberry tree.DNJ has been isolated and identified from mulberry(Morus L.),dayflower(Commelina communis),hyacinth(Hyacinthus orientalis) and adenophora(Adenophora triphylla var.japonica),among which mulberry has the highest content of DNJ.DNJ content of mulberry varies greatly with mulberry varieties,medicament portions,seasons,climates,geographical and soil conditions,leaf positions,and development stages etc.In microorganisms,DNJ was isolated from various species of streptomycete and bacillus.It was also discovered that two endophytes from mulberry,Stenotrophomonas maltophilia and Micrococcus luteus,could produce DNJ stably.So far,fermentation conditions for many microorganisms with DNJ production have been investigated.In insect,besides silkworm(Bombyx mori) which has rich content of DNJ,other mulberry monophagous insect species or oligophagous ones including Bombyx mandarina,Rondotia menciana,Phthonandria atrineata,and Diaphani apyloalis also have high content of DNJ.DNJ in insect body comes from their food,and DNJ content in silkworm body varies with silkworm species,developmental periods,diet,tissue and organ etc.It was also noticed that absorption and concentration of DNJ in silkworm body changed periodically with the advance of larval instar.Researches aiming to elucidate biosynthetic pathway of DNJ in streptomycete,bacillus,and dayflower have been conducted.It was found that DNJ synthetic pathway is different in different species.Important progress has been made in chemosynthesis of DNJ.Three major synthetic methods have been developed and some synthesized DNJ derivatives have been used in clinic.

Synthesis and glycosidase inhibition of 5-C-alkyl-DNJ and 5-C-alkyl-l-ido-DNJ derivatives

Synthesis and Biological Activity of Novel Deoxynojirimycin Derivatives As Potent Alpha-Glucosidase Inhibitors

Design, synthesis and glycosidase inhibition of C-4 branched LAB and DAB derivatives

Introduction of C-alkyl branches to L-iminosugars changes their active site binding orientation

Inhibition Mechanism of Α-Glucosidase by Three Geranylated Compounds: Kinetic, Spectroscopic and Molecular Docking

Nanomolar β-glucosidase and β-galactosidase inhibition by enantiomeric α-1- C -alkyl-1,4-dideoxy-1,4-imino-arabinitol derivatives

Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors

Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation

Synthesis of New Glucose-containing 5-Arylisoxazoles and their Enzyme Inhibitory Activity

Research Progress in Origin and Synthesis of 1-Deoxynojirimycin

Fluorescence sensing and glycosidase inhibition effect of multivalent glycosidase inhibitors based on Naphthalimide-deoxynojirimycin conjugates

Multivalent glucosidase inhibitors based on perylene bisimide and iminosugar conjugates

Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α‐glucosidase

Design, Synthesis and Biological Evaluation of Novel (E)-2-benzylidene-n-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide Derivatives As Α-Glucosidase Inhibitors.

In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase

Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation

Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies

New cycloalkyl[b]thiophenylnicotinamide-based -glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study,<i> in</i><i> vitro</i> and<i> in</i><i> vivo</i> evaluations

Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting α-amylase, and α-glucosidase: synthesis, molecular docking, and ADMET studies

Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation